Stockscreener 앱 받기
21.12
3.05%
-0.665
시간 외 거래:
21.12
전일 마감가:
$21.79
열려 있는:
$21.52
하루 거래량:
170.26K
Relative Volume:
1.28
시가총액:
$346.11M
수익:
$105.65M
순이익/손실:
$-216.77M
주가수익비율:
-1.1898
EPS:
-17.7511
순현금흐름:
$-225.11M
1주 성능:
-13.62%
1개월 성능:
+7.98%
6개월 성능:
+138.21%
1년 성능:
+157.31%
1일 변동 폭
$20.59
$22.25
1주일 범위
$20.59
$25.42
52주 변동 폭
$5.231
$26.54
Sutro Biopharma Inc Stock (STRO) Company Profile
명칭
Sutro Biopharma Inc
전화
650-392-8412
주소
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Compare STRO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
21.12 | 357.01M | 105.65M | -216.77M | -225.11M | -17.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-06-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-03-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-05-08 | 개시 | BofA Securities | Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-06 | 개시 | Oppenheimer | Outperform |
| 2023-03-21 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | 재개 | Wells Fargo | Overweight |
| 2021-06-18 | 개시 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-09-02 | 개시 | Jefferies | Buy |
| 2020-07-16 | 개시 | Wells Fargo | Overweight |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-10-07 | 개시 | BTIG Research | Buy |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2019-04-29 | 개시 | H.C. Wainwright | Buy |
| 2018-10-22 | 개시 | JMP Securities | Mkt Outperform |
| 2018-10-22 | 개시 | Piper Jaffray | Overweight |
| 2018-10-22 | 개시 | Wedbush | Outperform |
모두보기
Sutro Biopharma Inc 주식(STRO)의 최신 뉴스
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Aug Rallies: Why is Allegro MicroSystems Inc. stock going down2026 Update & Accurate Trade Setup Notifications - baoquankhu1.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 19.8% in February - MarketBeat
Sutro Biopharma: ADC Developer With Poor Track Record Aims For Positive 2026 (NASDAQ:STRO) - Seeking Alpha
Sutro Biopharma, Inc. to Present at 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026 - Quiver Quantitative
Fed Meeting: What is the Moat Score of Sutro Biopharma Inc2026 Retail & Daily Growth Stock Tips - baoquankhu1.vn
Sutro Biopharma (STRO) surges 11.9%: Is this an indication of further gains? - MSN
Sutro Biopharma Hits New 52-Week High of $25.68, Soars 556.88% - Markets Mojo
Sutro Biopharma Inc expected to post a loss of $4.34 a shareEarnings Preview - TradingView
Aug Swings: Can Sutro Biopharma Inc. continue delivering strong returns2026 Pullback Review & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Sutro Biopharma Hits New 52-Week High of $21.40, Soars 453% - Markets Mojo
Sutro Biopharma (STRO) GC exercises RSUs as shares withheld for taxes - Stock Titan
Sutro Biopharma Hits New 52-Week High at $20.47, Soars 430% - Markets Mojo
Sutro Biopharma Hits New 52-Week High of $20.93, Up 431.69% - Markets Mojo
Sutro Biopharma Hits New 52-Week High of $20.48, Up 431.69% - Markets Mojo
Sutro Biopharma (STRO) to Release Quarterly Earnings on Thursday - Defense World
Sutro Biopharma: Transformed leadership and advanced ADC pipeline drive clinical progress, with key data due mid-year - TradingView
Sutro Biopharma: Transformed leadership and advanced ADC platform drive rapid clinical progress and innovation - TradingView
Sutro Biopharma (STRO) GC reports new RSUs, options and tax share withholdings - Stock Titan
Sutro Biopharma (NASDAQ: STRO) CSO receives RSUs and options - Stock Titan
Sutro Biopharma (STRO) CFO awarded 40,000 options and 5,000 RSUs - Stock Titan
Sutro Biopharma (STRO) CEO receives RSU and option grants, shares withheld for taxes - Stock Titan
174,843 Shares in Sutro Biopharma, Inc. $STRO Purchased by GSA Capital Partners LLP - MarketBeat
Sutro Biopharma, Inc. (STRO) Presents at 16th Annual World ADC London SummitSlideshow - Seeking Alpha
STRO PE Ratio & Valuation, Is STRO Overvalued - Intellectia AI
STRO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sutro Biopharma to participate in key investor conferences - Traders Union
Sutro Biopharma to Participate in Upcoming Investor Conferences - marketscreener.com
Sutro Biopharma lines up March health-care investor talks in Boston and Miami - Stock Titan
Sutro Biopharma Announces Participation at the 16th World ADC London Summit - The Manila Times
World ADC London panels spotlight Sutro Biopharma’s dual-payload ADCs - Stock Titan
Earnings Miss: Is Sutro Biopharma Inc a stock for growth or value investors2025 Key Highlights & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Is Sutro Biopharma Inc. a stock for growth or value investorsQuarterly Portfolio Report & Accurate Buy Signal Notifications - mfd.ru
Is Sutro Biopharma Inc. in a bullish channelTrend Reversal & Low Drawdown Trading Strategies - mfd.ru
Levels Update: Should I invest in Sutro Biopharma Inc before earningsEarnings Overview Report & High Yield Equity Trading Tips - baoquankhu1.vn
Is Sutro Biopharma Inc. (S09) stock a contrarian opportunity2025 Macro Impact & Real-Time Chart Breakout Alerts - mfd.ru
STRO Technical Analysis & Stock Price Forecast - Intellectia AI
Suvretta Capital exits Sutro Biopharma (STRO), reports 0% beneficial stake - Stock Titan
Sutro Biopharma prices $110M common stock offering - MSN
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains? - Yahoo Finance
Jobs Data: Can Sutro Biopharma Inc deliver alpha2025 Market Outlook & Weekly Breakout Watchlists - baoquankhu1.vn
Sutro Biopharma prices $110 million common stock offering By Investing.com - Investing.com Nigeria
Performance Recap: Why is Sutro Biopharma Inc stock going downJuly 2025 Setups & Long-Term Capital Growth Strategies - baoquankhu1.vn
Sutro Biopharma Highlights ADC Platform in New Presentation - TipRanks
Sutro Biopharma Signs Underwriting Agreement With Leerink Partners and TD Securities (USA) - TradingView
Sutro Biopharma Stock Rises 8% After Announcement Of Pricing Of 7.9 Mln Shares - Nasdaq
Sutro Biopharma Prices $110 Mln Underwritten Offering; Stock Jumps 18% - RTTNews
Sutro Biopharma (STRO) Sees Joint Management in Upcoming Offerin - GuruFocus
Sutro Biopharma prices $110 million common stock offering - Investing.com
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering - Yahoo Finance
Sutro Biopharma Inc (STRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):